Mandate

Vinge advises Alder in connection with its new majority ownership in Powerbox International

August 30, 2013

Powerbox International is one of Europe's leading manufacturers and distributors of power converters and associated products. It now has a new majority owner in Alder, a private equity fund based in Stockholm, Sweden. Founded in 1974, Powerbox International develops, manufactures and markets power supply solutions in AC/DC or DC/DC, ranging from a few watts to tens of kilowatts for demanding applications and customers. The company has an international reach with subsidiaries in 16 countries in Europe, the US and the Asia/Pacific region.

Alder is the new majority owner, with Industrifonden as well as current and previous employees of the company remaining as minority shareholders. Alder is an active investor and will, together with management, develop the company so that it reaches its full potential. As part of the transaction, new capital is invested in the company to help strengthen the organisation to enable future growth.

Vinges team consisted primarily of partners Johan Larsson and Jonas Bergström and associates Gustav Jönsson, Linn Adelwald and Philip Watson.

Related

Vinge has advised Verisure in connection with its IPO on Nasdaq Stockholm

Vinge has advised Verisure plc (“Verisure”) in connection with its IPO on Nasdaq Stockholm. Following the publication of the prospectus on 29 September 2025, trading in Verisure’s shares commenced today, 8 October 2025.
October 08, 2025

Vinge has acted for Advania on the acquisition of smartvokat

smartvokat GmbH, a German-based consultancy specialising in digital transformation within the legal, risk, and compliance domains, will become part of Advania’s business unit Transformation & Automation.
October 08, 2025

Vinge has advised Egetis Therapeutics in connection with a directed share issue

Vinge has advised Egetis Therapeutics AB (publ) (“Egetis Therapeutics”), listed on Nasdaq Stockholm, in connection with a directed share issue whereby Egetis Therapeutics raised proceeds of approximately SEK 183 million before transaction costs.
October 06, 2025